Mackay Shields LLC’s NeoGenomics NEO Stock Holding History

Mackay Shields LLC’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,400	Closed	-$237K	–	1563
2020 Q3	$237K	Buy	+6,400	New	+$238K	﹤0.01%	1306
2020 Q2	–	Sell	-36,400	Closed	-$1M	–	1542
2020 Q1	$1M	Buy	+36,400	New	+$1.09M	0.01%	943
2019 Q3	–	Sell	-192,383	Closed	-$4.22M	–	1465
2019 Q2	$4.22M	Buy	192,383 +103,783	+117%	+$2.28M	0.03%	594
2019 Q1	$1.81M	Buy	88,600 +43,300	+96%	+$752K	0.01%	735
2018 Q4	$571K	Buy	+45,300	New	+$675K	﹤0.01%	1109

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Mackay Shields LLC's NEO Position: Q4 2020 in Review

Mackay Shields LLC sold out of NeoGenomics (NEO) in Q4 2020, closing a stake of 6,400 shares — an estimated $237K sold.

Mackay Shields LLC first reported a position in NEO in Q4 2018 and held it in 5 quarters. The position peaked at $4.22M in Q2 2019. 340 funds tracked by Wall St. Rank hold NEO as of Q4 2020.

Mackay Shields LLC reported no remaining NeoGenomics position as of Q4 2020 after selling out during the quarter.
Mackay Shields LLC sold 6,400 NeoGenomics shares in Q4 2020, an estimated $237K.
Mackay Shields LLC first reported a position in NeoGenomics in Q4 2018 and held it in 5 quarters.
Mackay Shields LLC's NeoGenomics position peaked at $4.22M in Q2 2019.
340 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2020.

Based on Mackay Shields LLC's 13F filing for Q4 2020, filed 16 Feb 2021.